Do mistletoe injections help against cancer?

Mistletoe therapy: Europe's favorite add-on, honestly tested

🩺 Medical review in progress. This page was researched and written from the published studies listed in the sources below. A named medical professional is reviewing it; their sign-off will appear here. Until then, read it as careful homework — and discuss anything you consider with your own doctor.

The bottom line Unlikely

Mistletoe injections are among Europe's most-used cancer add-ons, and we wanted the answer to be kinder. When mistletoe finally got a large, properly blinded test — 290 patients with advanced pancreatic cancer — it showed no survival benefit and no quality-of-life benefit. Decades of smaller, weaker studies claimed otherwise; the better the trial, the smaller the effect.

⚠️ Never instead of treatment — and not from a pharmacy in the US. Mistletoe extracts are prescription injections used under clinical supervision in Europe; they are not commercially available in the US outside trials, and raw mistletoe is poisonous to eat. No evidence supports using it in place of cancer treatment.

Here because of a specific diagnosis? This topic appears in our guides to: Pancreatic Cancer · Breast Cancer

What it is

Extracts of European mistletoe (Viscum album), injected under the skin, have been used in German-speaking countries for a century — the practice grew out of anthroposophic medicine, and brands like Iscador and Helixor are prescribed by many European oncology clinics as a supportive add-on. It is one of the few alternative therapies with a genuinely large trial record: more than fifty studies [1].

What the evidence says

  • The decades of small trials: a Cochrane review of 21 randomized trials found the evidence for survival weak, with hints of quality-of-life benefit during chemotherapy — and widespread methodological problems [2].
  • The pattern that matters: systematic reviews found the better the study design, the smaller the apparent benefit — the classic signature of an effect that isn't real [6].
  • The decisive test: the MISTRAL trial (2024) — double-blind, placebo-controlled, 290 patients with advanced pancreatic cancer, the very disease where older unblinded trials claimed dramatic benefit. Result: no survival difference (7.8 vs 8.3 months) and no quality-of-life difference [3]. The older positive trial it was designed to check had no placebo and stopped early [5].
  • The Johns Hopkins study people cite (2023) was a phase 1 of intravenous mistletoe in 21 patients: it established tolerable dosing — which is all a phase 1 can do. It proved safety of a dose, not benefit [4].
  • Mistletoe is not FDA-approved and U.S. guidelines do not recommend it [1].

What patients report

Many European patients value their mistletoe routine and report feeling stronger during chemo — and some clinicians believe the injections' mild fever response helps patients feel actively engaged in their care. Those feelings are real; the best-controlled data simply can't find an objective benefit behind them. If you've used mistletoe, we'd like to hear your experience: .

Safety

  • Generally well tolerated under supervision: injection-site redness, mild fever, flu-like symptoms, headache [1][4]. Rare allergic reactions, including anaphylaxis, are reported.
  • Raw mistletoe plants and berries are poisonous — extracts are made and dosed professionally.
  • Theoretical interactions with immune-stimulating treatments; tell your team before combining with immunotherapy.

If you're in Europe and considering it

As an add-on under a qualified clinician, mistletoe appears safe, and if the ritual and the warmth of care around it help you cope, that has worth we won't sneer at. Go in with open eyes: the best-quality evidence says it will not extend your life or measurably lift your quality of life, and it costs real money over months. Never let it substitute for effective treatment — and if a clinic sells it as a cancer cure, walk out.

Common questions

Europeans get mistletoe with chemo — does it extend life?

The best-controlled trial (290 patients, double-blind) found no survival benefit. Older positive trials were unblinded and are widely criticized.

Didn't Johns Hopkins prove mistletoe works?

No — their 2023 study was a phase 1 safety trial in 21 patients. It established a tolerable dose, nothing about effectiveness.

Will it at least help me feel better during chemo?

Possibly — but the evidence is mixed, and the highest-quality trials (including MISTRAL) found no quality-of-life benefit either.

Can I take mistletoe instead of chemotherapy?

No. There is no evidence mistletoe controls cancer, and skipping effective treatment for it would be a tragic trade.

Sources

  1. NCINational Cancer Institute, PDQ “Mistletoe Extracts”, Health Professional Version. cancer.gov
  2. CochraneHorneber M. et al. Cochrane review CD003297: mistletoe therapy in oncology — 21 randomized trials, weak survival evidence. cochranelibrary.com (update protocol)
  3. TrialWode K. et al. MISTRAL: double-blind, placebo-controlled trial of mistletoe extract in 290 patients with advanced pancreatic cancer — no survival or quality-of-life benefit. Deutsches Ärzteblatt International, 2024. PubMed
  4. TrialPaller C.J. et al. Phase I trial of intravenous mistletoe (Helixor M) in 21 patients with advanced cancer — safety and dosing only. Cancer Research Communications, 2023. PMC · trial registry
  5. TrialTröger W. et al. Earlier open-label pancreatic trial claiming survival benefit — no placebo, stopped early, widely criticized. European Journal of Cancer, 2013 (companion quality-of-life report: aerzteblatt.de).
  6. ReviewFreuding M. et al. Systematic reviews of mistletoe in oncology (two parts): most studies show no survival effect; higher-quality studies show smaller or no quality-of-life effects. Journal of Cancer Research and Clinical Oncology, 2019. Contrasting meta-analysis: BMC Complement Med
  7. MSKMemorial Sloan Kettering, About Herbs: Mistletoe (European). mskcc.org